BACKGROUND: Total brain volume is an integrated measure of health and may be an independent indicator of mortality risk independent of any one clinical or subclinical disease state. We investigate the association of brain volume to total and cause-specific mortality in a large nondemented stroke-free community-based cohort. METHODS: The analysis includes 3,543 men and women (born 1907-1935) participating in the Age, Gene, Environment Susceptibility-Reykjavik Study. Participants with a known brain-related high risk for mortality (cognitive impairment or stroke) were excluded from these analyses. Quantitative estimates of total brain volume, white matter, white matter lesions, total gray matter (GM; cortical GM and subcortical GM separately), and focal cerebral vascular disease were generated from brain magnetic resonance imaging. Brain atrophy was expressed as brain tissue volume divided by total intracranial volume, yielding a percentage. Mean follow-up duration was 7.2 (0-10) years, with 647 deaths. Cox regression was used to analyze the association of mortality to brain atrophy, adjusting for demographics, cardiovascular risk factors, and cerebral vascular disease. RESULTS: Reduced risk of mortality was significantly associated with higher total brain volume (hazard ratio, 95% confidence interval = 0.71, 0.65-0.78), white matter (0.85, 0.78-0.93), total GM (0.74, 0.68-0.81), and cortical GM (0.78, 0.70-0.87). Overall, the associations were similar for cardiovascular and noncardiovascular-related deaths. CONCLUSIONS: Independent of multiple risk factors and cerebral vascular damage, global brain volume predicts mortality in a large nondemented stroke-free community-dwelling older cohort. Total brain volume may be an integrated measure reflecting a range of health and with further investigation could be a useful clinical tool when assessing risk for mortality. Published by Oxford University Press on behalf of the Gerontological Society of America 2014.
BACKGROUND: Total brain volume is an integrated measure of health and may be an independent indicator of mortality risk independent of any one clinical or subclinical disease state. We investigate the association of brain volume to total and cause-specific mortality in a large nondemented stroke-free community-based cohort. METHODS: The analysis includes 3,543 men and women (born 1907-1935) participating in the Age, Gene, Environment Susceptibility-Reykjavik Study. Participants with a known brain-related high risk for mortality (cognitive impairment or stroke) were excluded from these analyses. Quantitative estimates of total brain volume, white matter, white matter lesions, total gray matter (GM; cortical GM and subcortical GM separately), and focal cerebral vascular disease were generated from brain magnetic resonance imaging. Brain atrophy was expressed as brain tissue volume divided by total intracranial volume, yielding a percentage. Mean follow-up duration was 7.2 (0-10) years, with 647 deaths. Cox regression was used to analyze the association of mortality to brain atrophy, adjusting for demographics, cardiovascular risk factors, and cerebral vascular disease. RESULTS: Reduced risk of mortality was significantly associated with higher total brain volume (hazard ratio, 95% confidence interval = 0.71, 0.65-0.78), white matter (0.85, 0.78-0.93), total GM (0.74, 0.68-0.81), and cortical GM (0.78, 0.70-0.87). Overall, the associations were similar for cardiovascular and noncardiovascular-related deaths. CONCLUSIONS: Independent of multiple risk factors and cerebral vascular damage, global brain volume predicts mortality in a large nondemented stroke-free community-dwelling older cohort. Total brain volume may be an integrated measure reflecting a range of health and with further investigation could be a useful clinical tool when assessing risk for mortality. Published by Oxford University Press on behalf of the Gerontological Society of America 2014.
Authors: T L Strassburger; H C Lee; E M Daly; J Szczepanik; J S Krasuski; M J Mentis; J A Salerno; C DeCarli; M B Schapiro; G E Alexander Journal: Stroke Date: 1997-07 Impact factor: 7.914
Authors: W T Longstreth; A M Arnold; T A Manolio; G L Burke; N Bryan; C A Jungreis; D O'Leary; P L Enright; L Fried Journal: Neuroepidemiology Date: 2000 Jan-Feb Impact factor: 3.282
Authors: Roberto Cabeza; Sander M Daselaar; Florin Dolcos; Steven E Prince; Matthew Budde; Lars Nyberg Journal: Cereb Cortex Date: 2004-04 Impact factor: 5.357
Authors: Charles DeCarli; Joseph Massaro; Danielle Harvey; John Hald; Mats Tullberg; Rhoda Au; Alexa Beiser; Ralph D'Agostino; Philip A Wolf Journal: Neurobiol Aging Date: 2005-04 Impact factor: 4.673
Authors: Reinhold Schmidt; Lenore J Launer; Lars-Göran Nilsson; Andrzej Pajak; Susanna Sans; Klaus Berger; Monique M Breteler; Maria de Ridder; Carole Dufouil; Rebecca Fuhrer; Simona Giampaoli; Albert Hofman Journal: Diabetes Date: 2004-03 Impact factor: 9.461
Authors: Shari R Waldstein; Gregory A Dore; Christos Davatzikos; Leslie I Katzel; Rao Gullapalli; Stephen L Seliger; Theresa Kouo; William F Rosenberger; Guray Erus; Michele K Evans; Alan B Zonderman Journal: Psychosom Med Date: 2017-04 Impact factor: 4.312
Authors: Tali Cukierman-Yaffe; Hertzel C Gerstein; Michael E Miller; Lenore J Launer; Jeff D Williamson; Karen R Horowitz; Faramarz Ismail-Beigi; Ronald M Lazar Journal: J Clin Endocrinol Metab Date: 2017-09-01 Impact factor: 5.958
Authors: Danielle Shaked; Zachary B Millman; Danielle L Beatty Moody; William F Rosenberger; Hui Shao; Leslie I Katzel; Christos Davatzikos; Rao P Gullapalli; Stephen L Seliger; Guray Erus; Michele K Evans; Alan B Zonderman; Shari R Waldstein Journal: PLoS One Date: 2019-05-09 Impact factor: 3.240
Authors: Clarisse F de Vries; Roger T Staff; Kimberly G Noble; Ryan L Muetzel; Meike W Vernooij; Tonya White; Gordon D Waiter; Alison D Murray Journal: Brain Imaging Behav Date: 2020-02 Impact factor: 3.978
Authors: J H Cole; S J Ritchie; M E Bastin; M C Valdés Hernández; S Muñoz Maniega; N Royle; J Corley; A Pattie; S E Harris; Q Zhang; N R Wray; P Redmond; R E Marioni; J M Starr; S R Cox; J M Wardlaw; D J Sharp; I J Deary Journal: Mol Psychiatry Date: 2017-04-25 Impact factor: 15.992